CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMSConfidential Separation Agreement And • April 4th, 2023 • Trupanion, Inc. • Hospital & medical service plans • Washington
Contract Type FiledApril 4th, 2023 Company Industry JurisdictionThis Confidential Separation Agreement and General Release of All Claims (“Agreement”) is made by and between Trupanion Managers USA, Inc. (“Company”) and [Executive Officer] (“Team Member”) effective as of [Date] with respect to the following facts:
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMSConfidential Separation Agreement And • October 30th, 2023 • Pricesmart Inc • Retail-variety stores • California
Contract Type FiledOctober 30th, 2023 Company Industry JurisdictionThis Confidential Separation Agreement and General Release of All Claims (“Agreement”) is made by and between Frank R. Diaz (“Employee” or “you”) and PriceSmart, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
CONFIDENTIAL SEPARATION AGREEMENT AND RELEASE IN FULLConfidential Separation Agreement And • January 4th, 2021 • Kelly Services Inc • Services-help supply services • Michigan
Contract Type FiledJanuary 4th, 2021 Company Industry Jurisdiction
CONFIDENTIAL SEPARATION AGREEMENT AND MUTUAL GENERAL RELEASE OF CLAIMSConfidential Separation Agreement And • May 15th, 2002 • Vantagemed Corp • Services-prepackaged software • California
Contract Type FiledMay 15th, 2002 Company Industry JurisdictionThis CONFIDENTIAL SEPARATION AGREEMENT AND MUTUAL GENERAL RELEASE OF CLAIMS (this "Agreement") is entered into as of May 13, 2002 (the "Effective Date") by and between, VantageMed Corporation, a Delaware corporation (the "Company"), and Joel Harris ("Harris").
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASEConfidential Separation Agreement And • October 10th, 2014 • Neurotrope, Inc. • Services-prepackaged software
Contract Type FiledOctober 10th, 2014 Company IndustryTHIS CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE (“Agreement”) is made and entered into by and between James New, PhD. (“Dr. New”) and Neurotrope BioScience, Inc. (the “Company”).